A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation

The AFFIRM Investigators·2002·New England Journal of Medicine

Cited by (1,005)

Items 201–300 of 1,005

  1. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland
    N. Murphy, Colin Simpson, P. Jhund, S. Stewart, M. Kirkpatrick, J. Chalmers, K. Macintyre, J. McMurray · 2007 · Heart
  2. Atrial flutter and fibrillation in patients with pulmonary hypertension
    Karen M. Olsson, Nils Patrick Nickel, Jörn Tongers, Marius M. Hoeper · 2012 · International Journal of Cardiology
  3. Present Status of Anticoagulation Treatment in Japanese Patients With Atrial Fibrillation - A Report From the J-RHYTHM Registry -
    Hirotsugu Atarashi, Hiroshi Inoue, Ken Okumura, Takeshi Yamashita, Naoko Kumagai, Hideki Origasa, The J-RHYTHM II Investigators · 2011 · Circulation Journal
  4. Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension
    Manolis, Athanasios J., Rosei, Enrico Agabiti, Coca, Antonio, Cifkova, Renata, Erdine, Serap E., Kjeldsen, Sverre, Lip, Gregory Y.H., Narkiewicz, Krzysztof, Parati, Gianfranco, Redon, Josep et al. · 2012 · Journal of Hypertension
  5. Recruitment of Immune Cells Across Atrial Endocardium in Human Atrial Fibrillation
    Takeshi Yamashita, Akiko Sekiguchi, Yu‐ki Iwasaki, Taro Date, Koichi Sagara, Hiroaki Tanabe, Hisayoshi Suma, Hitoshi Sawada, Tadanori Aizawa · 2010 · Circulation Journal
  6. Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial
    Ratika Parkash, George A. Wells, Jean Lucien Rouleau, Mario R. Talajic, Vidal Essebag, Allan Skanes, Stephen B. Wilton, Atul Verma, Jeff S. Healey, Laurence Sterns et al. · 2022 · Circulation
  7. Brugada syndrome: 1992–2002
    Charles N Antzelevitch, Pedro Brugada, Josép Brugada, Ramón Brugada, Jeffrey Allen Towbin, Kolawanee Nademanee · 2003 · Journal of the American College of Cardiology
  8. Rate control in atrial fibrillation
    Isabelle C. Van Gelder, Michiel Rienstra, Harry J.G.M. Crijns, Brian Olshansky · 2016 · The Lancet
  9. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
    Stephan Willems, Katrin Borof, Axel Brandes, GÜNTER E. BREITHARDT, A. John Camm, Harry J.G.M. Crijns, Lars Eckardt, Nele Geßler, Andreas Goette, Laurent Haegeli et al. · 2021 · European Heart Journal
  10. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial
    Gheorghiade, M., Fonarow, G. C., van Veldhuisen, D. J., Cleland, J. G. F., Butler, J., Epstein, A. E., Patel, K., Aban, I. B., Aronow, W. S., Anker, S. D. et al. · 2013 · European Heart Journal
  11. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis
    Hakalahti, A., Biancari, F., Nielsen, J. C., Raatikainen, M. J. P. · 2015 · Europace
  12. Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades
    Miyasaka, Yoko, Barnes, Marion E., Gersh, Bernard J., Cha, Stephen S., Bailey, Kent R., Abhayaratna, Walter, Seward, James B., Iwasaka, Toshiji, Tsang, Teresa S.M. · 2006 · European Heart Journal
  13. Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: The Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study
    Matthew R. Reynolds, Tara A. Lavelle, Vidal Essebag, David J. Cohen, PETER J. ZIMETBAUM · 2006 · American Heart Journal
  14. Initial Independent Outcomes from Focal Impulse and Rotor Modulation Ablation for Atrial Fibrillation: Multicenter FIRM Registry
    John M. Miller, Robert C. Kowal, Vijay Swarup, James P. Daubert, Emile G. Daoud, JOHN D. DAY, Kenneth A. Ellenbogen, John D. Hummel, Tina Baykaner, David E. Krummen et al. · 2014 · Journal of Cardiovascular Electrophysiology
  15. Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: Results from the RAte Control versus Electrical cardioversion (RACE) study
    Vincent E. Hagens, Harry J.G.M. Crijns, Dirk Jan van Veldhuisen, Maarten P. van den Berg, Michiel Rienstra, Adelita V. Ranchor, Hans A. Bosker, Otto Kamp B, Jan G.P. Tijssen, Nic J.G.M. Veeger et al. · 2005 · American Heart Journal
  16. Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation
    Mohit K. Turagam, Daniel Ross Musikantow, William Whang, Jacob Sam Koruth, Marc A. Miller, Marie-Noelle S. Langan, Aamir A. Sofi, Subbarao Choudry, Srinivas Rao Dukkipati, Vivek Yerrapu Reddy · 2021 · JAMA Cardiology
  17. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
    Gallego, Pilar, Roldan, Vanessa, Marín, Francisco, Romera, Marta, Valdés, Mariano, Vicente, Vicente, Lip, Gregory Y. H. · 2013 · Thrombosis and Haemostasis
  18. Obesity and Metabolic Syndrome Are Independent Risk Factors for Atrial Fibrillation After Coronary Artery Bypass Graft Surgery
    Najmeddine Echahidi, Dania Mohty, Philippe Pîbarot, Jean‐Pierre Després, Gilles E O’Hara, Jean Champagne, François Philippon, Pascal Daleau, Pierre Voisine, Patrick Mathieu · 2007 · Circulation
  19. Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway
    Marco Proietti, Giulio Francesco Romiti, Brian Olshansky, Deirdre A. Lane, Gregory Y.H. Lip · 2018 · The American Journal of Medicine
  20. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillationResults from a prospective randomized study
    GRONEFELD, G · 2003 · European Heart Journal
  21. Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis
    Imad Abi Nasr, Anissa Bouzamondo, Jean‐Sébastien Hulot, O. Dubourg, Jean Yves Le Heuzey, Philippe P. Lechat · 2007 · European Heart Journal
  22. Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation
    Margaret C. Fang, Alan S. Go, Yuchiao Chang, Leila H. Borowsky, Niela K. Pomernacki, Natalia V. Udaltsova, Daniel E. Singer · 2010 · Circulation Cardiovascular Quality and Outcomes
  23. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death
    Hunter, Ross J, McCready, James, Diab, Ihab, Page, Stephen P, Finlay, Malcolm, Richmond, Laura, French, Antony, Earley, Mark J, Sporton, Simon, Jones, Michael et al. · 2012 · Heart
  24. Direct His‐Bundle Pacing:
    Pramod M. Deshmukh, Mary A. Romanyshyn · 2004 · Pacing and Clinical Electrophysiology
  25. Detection of atrial high-rate events by continuous Home Monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population
    Nesan Shanmugam, A. Boerdlein, Jochen Proff, P. Ong, Oswaldo Valencia, Sebastian K.G. Maier, Wolfgang R. Bauer, V. E. Paul, S. Sack · 2011 · EP Europace
  26. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFÉ-II Study)
    Rhidian J. Shelton, Andrew L. Clark, Kevin M Goode, Alan S. Rigby, Timothy Houghton, Gerry Kaye, John G.F. Cleland · 2009 · Heart
  27. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials
    Greg C. Flaker, Michael J. Gruber, Stuart J. Connolly, Steven Marc Goldman, Sandra Viviana Chaparro, Alec S. Vahanian, Matti Halinen, Jay Charles Horrow, Jonathan L. Halperin · 2006 · American Heart Journal
  28. Amiodarone: guidelines for use and monitoring.
    Lyle A. Siddoway · 2003 · PubMed
  29. Causes of Death and Influencing Factors in Patients with Atrial Fibrillation
    Laurent Fauchier, Olivier Villejoubert, Nicolas Clémenty, Anne Brunet Bernard, Bertrand Pierre, Denis Angoulvant, Fabrice Ivanés, Dominique Babuty, Gregory Y.H. Lip · 2016 · The American Journal of Medicine
  30. Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation
    Christoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, Walter Lehmacher, Werner G. Daniel, Peter Hanrath, J. Christoph Geller, Andreas Mügge, Walter Sehnert, Caroline Schmidt‐Lucke et al. · 2004 · Circulation
  31. Controversies in atrial fibrillation
    Stanley Nattel, Lionel Henry Opie · 2006 · The Lancet
  32. Rate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation: A Systematic Review
    Al-Khatib, Sana M., Allen LaPointe, Nancy M., Chatterjee, Ranee, Crowley, Matthew J., Dupre, Matthew E., Kong, David F., Lopes, Renato D., Povsic, Thomas J., Raju, Shveta S., Shah, Bimal et al. · 2014 · Annals of Internal Medicine
  33. The future of atrial fibrillation management: integrated care and stratified therapy
    Paulus F. Kirchhof · 2017 · The Lancet
  34. Real-Life Observations of Clinical Outcomes With Rhythm- and Rate-Control Therapies for Atrial Fibrillation
    A. John Camm, GÜNTER E. BREITHARDT, Harry J.G.M. Crijns, Paul Dorian, Peter Russell Kowey, Jean‐Yves Le Heuzey, Ihsen Merioua, Laurence Pedrazzini, Eric N. Prystowsky, Peter J. Schwartz et al. · 2011 · Journal of the American College of Cardiology
  35. Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study
    Daehoon Kim, Pil‐Sung Yang, Seng Chan You, Jung‐Hoon Sung, Eunsun Jang, Hee Tae Yu, Tae‐Hoon Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Gregory Y.H. Lip et al. · 2021 · BMJ
  36. Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation
    Maurizio Gasparini, Christophe Leclercq, Maurizio Lunati, Maurizio Landolina, Angelo Auricchio, Massimo Santini, Giuseppe Boriani, Barbara Lamp, Alessandro Proclemer, Antonio Curnis et al. · 2013 · JACC Heart Failure
  37. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials
    Gerald V. Naccarelli, Deborah L. Wolbrette, M. Rashid Khan, Luna Bhatta, John K. Hynes, Soraya M Samii, Jerry C. Luck · 2003 · The American Journal of Cardiology
  38. Functional Status in Rate- Versus Rhythm-Control Strategies for Atrial Fibrillation
    Mina K. Chung, Lynn R. Shemanski, David G. Sherman, H.Leon Greene, David B. Hogan, Joyce C. Kellen, Soo Gyum Kim, Lisa Warsinger Martin, Yves Rosenberg, D. George Wyse · 2005 · Journal of the American College of Cardiology
  39. Status of Women in Cardiovascular Clinical Trials
    Esther S.H. Kim, Venu Menon · 2009 · Arteriosclerosis Thrombosis and Vascular Biology
  40. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006
    Henry Krum, Michael V Jelinek, Simon Stewart, Andrew Paul Sindone, John James Atherton, Anna L. Hawkes · 2006 · The Medical Journal of Australia
  41. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
    Gregory Y.H. Lip, Marco Proietti, Tatjana Potpara, MOUSSA C. MANSOUR, Irina Savelieva, Hung‐Fat Tse, Andreas Goette, A. John Camm, Carina Blomström‐Lundqvist, Dhiraj Gupta et al. · 2023 · EP Europace
  42. Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
    Etienne Aliot, Alessandro Capucci, Harry J.G.M. Crijns, Andreas Goette, Juan Luis Tamargo · 2010 · EP Europace
  43. Progressive Nature of Paroxysmal Atrial Fibrillation-Observations From a 14-Year Follow-up Study-
    Takeshi Kato, Takeshi Yamashita, Kouichi Sagara, Hiroyuki Iinuma, Long-tai Fu · 2004 · Circulation Journal
  44. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies
    Van Gelder, Isabelle C., Wyse, D. George, Chandler, Mary L., Cooper, Howard A., Olshansky, Brian, Hagens, Vincent E., Crijns, Harry J.G.M. · 2006 · EP Europace
  45. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy
    FORLEO, GIOVANNI B., MANTICA, MASSIMO, DE LUCA, LUCIA, LEO, ROBERTO, SANTINI, LUCA, PANIGADA, STEFANIA, DE SANCTIS, VALERIO, PAPPALARDO, AUGUSTO, LAURENZI, FRANCESCO, AVELLA, ANDREA et al. · 2009 · Journal of Cardiovascular Electrophysiology
  46. Natural History and Long-Term Outcomes of Ablated Atrial Fibrillation
    Ayman Ali Hussein, Walid I. Saliba, David O. Martin, Mandeep Bhargava, Minerva Sherman, Christina Magnelli-Reyes, Mohammed A. Chamsi‐Pasha, Seby John, Michelle Williams‐Andrews, Bryan J. Baranowski et al. · 2011 · Circulation Arrhythmia and Electrophysiology
  47. Translational Challenges in Atrial Fibrillation
    Jordi Heijman, Jean-Baptiste Guichard, Dobromir Dobrev, Stanley Nattel · 2018 · Circulation Research
  48. Cardiac Arrhythmias: Diagnosis, Symptoms, and Treatments
    Du-Guan Fu · 2015 · Cell Biochemistry and Biophysics
  49. Accuracy of Atrial Tachyarrhythmia Detection in Implantable Devices with Arrhythmia Therapies
    Helmut Pürerfellner, Anne M. Gillis, Reece Holbrook, Douglas A. Hettrick · 2004 · Pacing and Clinical Electrophysiology
  50. Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data
    Shaojie Chen, Helmut Pürerfellner, Christian G. Meyer, Willem‐Jan Acou, Alexandra Schratter, Zhiyu Ling, Shaowen Liu, Yuehui Yin, Martin Martinek, Márcio Galindo Kiuchi et al. · 2019 · European Heart Journal
  51. Catheter Ablation for Atrial Fibrillation
    Mark D O'Neill, Pierre Jaı̈s, Mélèze Hocini, Frédéric Sacher, George Joseph Klein, Jacques Clémenty, Michel Haı̈ssaguerre · 2007 · Circulation
  52. Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation
    Cees B. de Vos, Bob Weijs, Harry J.G.M. Crijns, Emile C. Cheriex, Andrea Palmans, Jos Habets, Martin H. Prins, Ron Pisters, Robby Nieuwlaat, Robert G. Tieleman · 2008 · Heart
  53. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial
    Kirchhof, Paulus, Breithardt, Günter, Camm, A. John, Crijns, Harry J., Kuck, Karl-Heinz, Vardas, Panos, Wegscheider, Karl · 2013 · American Heart Journal
  54. Optimized Implementation of Cardiac Resynchronization Therapy: A Call for Action for Referral and Optimization of Care
    Wilfried Müllens, Angelo Auricchio, Pieter Martens, Klaus K. Witte, Martín Cowie, Victoria Delgado, Kenneth Dickstein, Cecilia Marianne Linde, Kevin Vernooy, Francisco Leyva et al. · 2020 · European Journal of Heart Failure
  55. Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials
    David M. Kent, Jason Nelson, Issa J Dahabreh, Peter Malcolm Rothwell, Douglas G. Altman, Rodney A. Hayward · 2016 · International Journal of Epidemiology
  56. Atrial fibrillation burden: a new outcome predictor and therapeutic target
    Nina Becher, Andreas Metzner, Tobias Toennis, Paulus F. Kirchhof, Renate B. Schnabel · 2024 · European Heart Journal
  57. Contemporary Approach to Aortic and Mitral Regurgitation
    JEFFREY S. BORER, Robert O. Bonow · 2003 · Circulation
  58. Are Transthoracic Echocardiographic Parameters Associated With Atrial Fibrillation Recurrence or Stroke?
    Brian Olshansky, Eliot N. Heller, L. Brent Mitchell, Mary L. Chandler, William Slater, Martin S. Green, Michael A. Brodsky, Patrick Barrell, H.Leon Greene · 2005 · Journal of the American College of Cardiology
  59. The Effect of Rate Control on Quality of Life in Patients With Permanent Atrial Fibrillation
    Groenveld, Hessel F., Crijns, Harry J.G.M., Van den Berg, Maarten P., Van Sonderen, Eric, Alings, A. Marco, Tijssen, Jan G.P., Hillege, Hans L., Tuininga, Ype S., Van Veldhuisen, Dirk J., Ranchor, Adelita V. et al. · 2011 · Journal of the American College of Cardiology
  60. 2018 Korean Guideline of Atrial Fibrillation Management
    Boyoung Joung, Jung‐Myung Lee, Ki Hong Lee, Tae‐Hoon Kim, Eue‐Keun Choi, Woo‐Hyun Lim, Ki‐Woon Kang, Jae‐Sun Uhm, Hong Euy Lim, Junbeom Park et al. · 2018 · Korean Circulation Journal
  61. Animal models for atrial fibrillation: clinical insights and scientific opportunities
    Kunihiro Nishida, Georghia Michael, Dobromir Dobrev, Stanley Nattel · 2009 · EP Europace
  62. Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode
    Francisco G. Cosío, Etienne Aliot, Gianluca Botto, Hein Heidbuchel, J. Christoph Geller, Paulus F. Kirchhof, J.-C. De Haro, Robert Frank, Julián Pérez‐Villacastín, Johan M. Vijgen et al. · 2007 · EP Europace
  63. Cost-Effectiveness of Radiofrequency Catheter Ablation Compared With Antiarrhythmic Drug Therapy for Paroxysmal Atrial Fibrillation
    Matthew R. Reynolds, PETER J. ZIMETBAUM, Mark E. Josephson, E. Ellis, Tatyana Danilov, David J. Cohen · 2009 · Circulation Arrhythmia and Electrophysiology
  64. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey
    Ron Pisters, Robby Nieuwlaat, Martin H. Prins, Jean Yves Le Heuzey, Aldo Pietro Maggioni, A. John Camm, Harry J.G.M. Crijns, for the Euro Heart Survey Investigators · 2012 · EP Europace
  65. Atrial Fibrillation in Congestive Heart Failure
    Steven A. Lubitz, Emelia J. Benjamin, Patrick T. Ellinor · 2010 · Heart Failure Clinics
  66. Catheter Ablation of Atrial Fibrillation in Octogenarians: Safety and Outcomes
    Pasquale Santangeli, Luigi Di Biase, Prasant Kumar Mohanty, J. David Burkhardt, Rodney Horton, Rong Bai, Sanghamitra Mohanty, Agnes Pump, Douglas N Gibson, Linda Couts et al. · 2012 · Journal of Cardiovascular Electrophysiology
  67. Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011)
    JCS Joint Working Group · 2012 · Circulation Journal
  68. ACC/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Atrial Fibrillation
    Robert L. McNamara, Lawrence M. Brass, Joseph P. Drozda, Alan S. Go, Jonathan L. Halperin, Charles R. Kerr, Samuel Lévy, David J. Malenka, Suneet Mittal, Frank Pelosi et al. · 2004 · Circulation
  69. Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design
    Douglas L. Packer, Daniel B. Mark, Richard A. Robb, Kristi H. Monahan, Tristram D. Bahnson, Kathleen Moretz, Jeanne E. Poole, Alice M. Mascette, Yves Rosenberg, Neal O. Jeffries et al. · 2018 · American Heart Journal
  70. Atrial Fibrillation: Mechanisms, Therapeutics, and Future Directions
    Jason Pellman, Farah Sheikh · 2015 · Comprehensive physiology
  71. Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?
    PETER J. ZIMETBAUM, Amit J. Thosani, Hsing-Ting Yu, Yan Xiong, Jay Lin, Prajesh Kothawala, Matthew F Emons · 2010 · The American Journal of Medicine
  72. Management of Newly Detected Atrial Fibrillation: A Clinical Practice Guideline from the American Academy of Family Physicians and the American College of Physicians
    Vincenza T. Snow, Kevin B. Weiss, Michael LeFevre, Robert McNamara, Eric B Bass, Lee A. Green, Keith Michl, Douglas K Owens, Jeffrey Susman, Deborah I. Allen et al. · 2003 · Annals of Internal Medicine
  73. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
    Jeffrey B. Washam, Susanna R. Stevens, Yuliya V. Lokhnygina, Jonathan L. Halperin, GÜNTER E. BREITHARDT, Daniel E. Singer, Kenneth W. Mahaffey, Graeme J. Hankey, Scott D. Berkowitz, Christopher C. Nessel et al. · 2015 · The Lancet
  74. Comparative Effectiveness of Rhythm Control vs Rate Control Drug Treatment Effect on Mortality in Patients With Atrial Fibrillation
    Raluca Ionescu‐Ittu, Michał Abrahamowicz, Cynthia Anne Jackevicius, Vidal Essebag, Mark Jeffrey Eisenberg, Willy Wynant, Hugues Richard, Louise Pilote · 2012 · Archives of Internal Medicine
  75. Maintenance of Sinus Rhythm and Survival in Patients With Heart Failure and Atrial Fibrillation
    Mario R. Talajic, Paul Khairy, Sylvie Lévesque, Stuart J. Connolly, Paul Dorian, Marc Dubuc, Peter G. Guerra, Stefan Hans Hohnloser, Kerry L. Lee, Laurent Macle et al. · 2010 · Journal of the American College of Cardiology
  76. Management of Atrial Fibrillation in Patients With Structural Heart Disease
    Andrew E. Darby, John Dimarco · 2012 · Circulation
  77. Dronedarone
    Chinmay Patel, Gan‐Xin Yan, Peter Russell Kowey · 2009 · Circulation
  78. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery
    Eugene Crystal, Michael Stuart Garfinkle, Stuart J. Connolly, Tracy J. Ginger, Khaled Sleik, Salim Yusuf · 2004 · Cochrane Database of Systematic Reviews
  79. Review of epidemiology and management of atrial fibrillation in developing countries
    Nguyen, Tu N., Hilmer, Sarah N., Cumming, Robert G. · 2013 · International Journal of Cardiology
  80. Plasma B-Type Natriuretic Peptide Levels and Recurrent Arrhythmia After Successful Ablation of Lone Atrial Fibrillation
    Ayman Ali Hussein, Walid I. Saliba, David O. Martin, Mazyar S. Shadman, Mohamed Hani Kanj, Mandeep Bhargava, Thomas Dresing, Mina K. Chung, Thomas D. Callahan, Bryan J. Baranowski et al. · 2011 · Circulation
  81. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
    Chern‐En Chiang, Tsu-Juey Wu, Kwo-Chang Ueng, Tze‐Fan Chao, Kuan‐Cheng Chang, Chun-Chieh Wang, Yenn‐Jiang Lin, Wei‐Hsian Yin, Jen‐Yuan Kuo, Wei‐Shiang Lin et al. · 2016 · Journal of the Formosan Medical Association
  82. Atrial fibrillation and stroke: State-of-the-art and future directions
    Sandra Elsheikh, Andrew M. Hill, Greg J Irving, Gregory Y.H. Lip, Azmil H. Abdul‐Rahim · 2023 · Current Problems in Cardiology
  83. Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
    Teruhiko Terasawa, Ethan M. Balk, Mei Chun Chung, Ann C. Garlitski, Alawi A.A. Alsheikh-Ali, Joseph Lau, Stanley Ip · 2009 · Annals of Internal Medicine
  84. Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008)
    JCS Joint Working Group · 2010 · Circulation Journal
  85. Association Between Lipid Profile and Risk of Atrial Fibrillation - Niigata Preventive Medicine Study -
    Hiroshi Watanabe, Naohito Tanabe, Nobue Yagihara, Toru Watanabe, Yoshifusa Aizawa, Makoto Kodama · 2011 · Circulation Journal
  86. Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles
    Andreas Goette, Alicja Bukowska, Dobromir Dobrev, Jan Pfeiffenberger, Henning Morawietz, Denis Strugala, Ingrid Wiswedel, Friedrich Wilhelm Röhl, Carmen Wolke, S. Bergmann et al. · 2009 · European Heart Journal
  87. Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management)
    Sanjeev V. Saksena, April E Slee, Albert L. Waldo, Nick Freemantle, Mathew R Reynolds, Yves Rosenberg, Snehal Rathod, Shannon Grant, Elizabeth Thomas, D. George Wyse · 2011 · Journal of the American College of Cardiology
  88. Midterm survival in patients treated for atrial fibrillation: A propensity-matched comparison to patients without a history of atrial fibrillation
    Richard Lee, Patrick M. McCarthy, Edward C. Wang, Muthiah Vaduganathan, Jane T. Kruse, S. Chris Malaisrie, Edwin C. McGee · 2012 · Journal of Thoracic and Cardiovascular Surgery
  89. Importance of non–pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction
    Yonghui Zhao, Luigi Di Biase, Chintan G. Trivedi, Sanghamitra Mohanty, Rong Bai, Prasant Kumar Mohanty, Carola Gianni, Pasquale Santangeli, Rodney Horton, Javier Sánchez et al. · 2015 · Heart Rhythm
  90. Guidelines for Reporting Data and Outcomes for the Surgical Treatment of Atrial Fibrillation
    Richard Jay Shemin, James L. Cox, Alan Marc Gillinov, Eugene H. Blackstone, Charles R. Bridges · 2007 · The Annals of Thoracic Surgery
  91. Tachycardia mediated cardiomyopathy: Pathophysiology, mechanisms, clinical features and management
    Shuchita Gupta, Vincent M. Figueredo · 2014 · International Journal of Cardiology
  92. New-onset atrial fibrillation in adult critically ill patients: a scoping review
    Mik Wetterslev, Nicolai Haase, Christian Hassager, Emilie P. Belley‐Côté, William F. McIntyre, Youzhong An, Jiawei Shen, Alexandre Biasi Cavalcanti, Fernando Godinho Zampieri, Hélio Penna Guimarães et al. · 2019 · Intensive Care Medicine
  93. Previously Known and Newly Diagnosed Atrial Fibrillation: A Major Risk Indicator After a Myocardial Infarction Complicated by Heart Failure or Left Ventricular Dysfunction
    Lars Køber, Karl B Swedberg, John J.V. McMurray, Marc Alan Pfeffer, Eric J. Velazquez, Rafael Díaz, Aldo Pietro Maggioni, Mareev VIu, Grzegorz Opolski, Frans Van de Werf et al. · 2006 · European Journal of Heart Failure
  94. Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008) : Digest Version
    Satoshi Ogawa, Yoshifusa Aizawa, Hirotsugu Atarashi, Hiroshi Inoue, Shiro Kamakura, Yukihiro Koretsune, Koichiro Kumagai, Hideo Mitamura, Ken Okumura, Kaoru Sugi et al. · 2010 · Japanese Circulation Journal-english Edition
  95. Quality of Care for Atrial Fibrillation Among Patients Hospitalized for Heart Failure
    Jonathan Paul Piccini, Adrian F. Hernandez, Xin Zhao, Manesh R. Patel, William R. Lewis, Eric David Peterson, Gregg C. Fonarow · 2009 · Journal of the American College of Cardiology
  96. JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
    Katsushige Ono, Yu‐ki Iwasaki, Masaharu Akao, Takanori Ikeda, Kuniaki Ishii, Yasuya Inden, Kengo Kusano, Yoshinori Kobayashi, Yukihiro Koretsune, Tetsuo Sasano et al. · 2022 · Circulation Journal
  97. Rhythm Versus Rate Control Therapy and Subsequent Stroke or Transient Ischemic Attack in Patients With Atrial Fibrillation
    Meytal Avgil Tsadok, Cynthia Anne Jackevicius, Vidal Essebag, Mark Jeffrey Eisenberg, Elham Rahme, Karin H. Humphries, Jack V. Tu, Hassan Behlouli, Louise Pilote · 2012 · Circulation
  98. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Management of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department
    Ian Gilmour Stiell, Laurent Macle · 2011 · Canadian Journal of Cardiology
  99. Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
    Theresa A. McDonagh, Marco Metra, Marianna Adamo, Roy S. Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Dragomir Chioncel et al. · 2022 · Revista Española de Cardiología
  100. Arrhythmias in Pulmonary Arterial Hypertension
    Archana Rajdev, Hasan Garan, ANGELO B. BIVIANO · 2012 · Progress in Cardiovascular Diseases